Please be aware that Mahajan Imaging & Labs will never request for your bank details or OTP for booking/registration purposes.

About the package:

The Dementia/Alzheimer Comprehensive Package is a specialized diagnostic assessment designed to support the early detection and evaluation of Alzheimer’s disease and other cognitive disorders. It combines advanced blood biomarkers, essential laboratory investigations, and specialized brain imaging to assess brain health, identify potential underlying causes of memory decline, and detect changes associated with neurodegenerative conditions. This comprehensive approach helps clinicians make informed decisions for timely diagnosis, treatment planning, and ongoing cognitive health management.

Additional Information

Tests: KIDNEY PANEL KFT BASIC, LIVER PANEL LFT BASIC, HbA1c GLYCOSYLATED HEMOGLOBIN, VITAMIN B12 - CYANOCOBALAMIN, COMPLETE BLOOD COUNT WITH ESR (CBC+ESR), TSH (THYROID STIMULATING HORMONE) ULTRASENSITIVE, C-REACTIVE PROTEIN; CRP, VITAMIN D 25-HYDROXY, MRI BRAIN WITH DEMENTIA PROTOCOL, HOMOCYSTEINE QUANTITATIVE SERUM, Dementia/Alzheimers Biomarker Panel (Plasma pTau217/ ß-Amylo (Plasma pTau217/ ß-Amyloid 1-42 Ratio), FDG PET CT BRAIN PLAIN (FDG ISOTOPE CHARGES EXTRA)
Parameters: 32
Recommended for: M/F/Others
Sample Type: Blood
Patient Preparation: No prior preparation is needed
Reports: 24 working hours

FAQs

Why is the Alzheimer Comprehensive Package performed?

This package is performed to investigate memory loss, confusion, behavioral changes, or other cognitive concerns. It helps clinicians detect biomarkers associated with Alzheimer's disease and identify reversible causes of cognitive decline, enabling timely diagnosis and appropriate treatment planning.

Who should consider getting this package?

People experiencing memory problems, difficulty concentrating, personality changes, or declining cognitive abilities may benefit from this package. Individuals with a family history of Alzheimer's disease or those at higher risk may also consider testing after consulting their doctor.

What is pTau 217 and why is it important?

pTau 217 is a blood biomarker associated with abnormal tau protein accumulation, one of the hallmarks of Alzheimer's disease. Elevated levels may indicate Alzheimer's-related brain changes, making it valuable for supporting diagnosis alongside clinical evaluation and imaging.

What is the β-Amyloid 42 ratio?

The β-Amyloid 42 ratio measures amyloid proteins in the blood that are linked to Alzheimer's disease. An abnormal ratio may suggest amyloid plaque formation in the brain, helping physicians assess the likelihood of Alzheimer's pathology.

Why are Vitamin B12 and Vitamin D included in this package?

Deficiencies of Vitamin B12 and Vitamin D can contribute to memory impairment, confusion, and cognitive dysfunction. Measuring these vitamins helps identify potentially reversible causes of cognitive symptoms that can be corrected with appropriate treatment.

Recommend more for you

Book Your Test
Text copied to clipboard
Dynamic badges will be added here